Advertisement
Screener

Biohaven Ltd. (BHVN) ROE

Biohaven Ltd. (BHVN) ROE

  • 2026-06-30: ROE -4801.51%.
  • 2026-03-31: ROE -500.14%.
  • 2025-12-31: ROE -1418.85%.
  • 2025-09-30: ROE 4546.10%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-4801.51%
2026-03-31-500.14%
2025-12-31-1418.85%
2025-09-304546.10%
2025-06-30-569.87%
2025-03-31-342.43%
2024-12-31-199.89%
2024-09-30-254.53%
2024-06-30-194.56%
2024-03-31-171.57%
2023-12-31-95.37%
2023-09-30-160.18%
2023-06-30-111.24%
2023-03-31-115.14%
2022-12-31-105.85%
2022-09-30-420.15%
2022-06-30-1626.41%
2022-03-31-539.50%
2021-12-31-616.29%

Annual ROE

DateROE
2025-12-31-1418.85%
2024-12-31-199.89%
2023-12-31-95.37%
2022-12-31-105.85%
2021-12-31-616.29%
2020-12-31-707.16%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Generate Biomedicines, Inc. (GENB)United States$2.052B
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55